ProPhase Labs Revenue, Profits - PRPH Annual Income Statement

Add to My Stocks
$3 $0.01 (0.33%) PRPH stock closing price Sep 19, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the ProPhase Labs stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $9.86M for 2017 impacts the PRPH stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the ProPhase Labs profit and loss statement for 2017 total to $5.5M. This line item shows that the operating expenses has decreased compared with last year. Also check: ProPhase Labs assets and ProPhase Labs free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
ProPhase Labs Revenues or Net Sales
9.86M21.01M20.6M22.07M25.03M22.4M17.45M14.5M19.81M20.5M
Cost Of Goods Sold (COGS)7.91M10.94M8.42M7.89M8.36M8.15M6.17M5.67M8.24M9.09M
ProPhase Labs Gross Profit
1.94M10.06M12.17M14.17M16.67M14.25M11.28M8.83M11.56M11.41M
Research & Development Expense--1.07M1.32M-1.3M1.08M-1.3M4.24M
Selling General & Admin Expense5.5M12.14M14.68M20.68M15.43M14.04M12.93M11.63M14.19M13.9M
Income Before Depreciation Depletion Amortization-3.99M-2.65M-3.58M-7.82M--1.09M-2.73M-3.59M-3.93M-6.72M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
ProPhase Labs Pretax Income
-3.66M-2.86M-3.6M-7.83M--1.09M-2.71M-3.54M-3.92M-6.4M
Provision for Income Taxes-17.99M-------0.04M-0.08M-
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations14.32M-2.86M-3.6M-7.83M--1.09M-2.71M-3.5M-3.84M-6.4M
Extraordinary Items & Discontinued Operations27.5M---------
ProPhase Labs Profit/ Loss (Net Income)
41.83M-2.86M-3.6M-7.83M--1.09M-2.71M-3.5M-3.84M-5.53M
Average Shares used to compute Diluted EPS15.7M17.08M16.4M16.77M16.28M14.84M14.82M14.29M12.96M12.88M
Average Shares used to compute Basic EPS15.57M17.08M16.4M16.77M15.84M14.84M14.82M14.29M12.96M12.88M
Income Before Nonrecurring Items14.86M-2.87M-3.6M-4.26M--2.12M-2.71M-3.5M-3.84M-6.41M
Income from Nonrecurring Items----3.58M-1.02M----
ProPhase Labs Earnings Per Share Basic Net
2.69-0.17-0.22-0.470.03-0.07-0.18-0.25-0.30-0.43
ProPhase Labs Earnings Per Share Diluted Net
2.67-0.17-0.22-0.460.03-0.07-0.18-0.25-0.30-0.43
EPS Diluted Before Nonrecurring Items0.92-0.17-0.22-0.250.03-0.14-0.18-0.25-0.30-0.50
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on ProPhase Labs stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $9.86M for this year of 2017. Our ProPhase Labs revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $41.83M for ProPhase Labs for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The PRPH financials along with ProPhase Labs historical stock prices provide a lot of details about the firm.

ProPhase Labs Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
10.56
PS Ratio (price sales ratio)
2.47
Dividend Yield
33.33%